2020
DOI: 10.1002/anie.201916524
|View full text |Cite
|
Sign up to set email alerts
|

MDM2‐Associated Clusterization‐Triggered Emission and Apoptosis Induction Effectuated by a Theranostic Spiropolymer

Abstract: Figure 4. A-C) The CLSM imaging of HepG2 cells with DCFH/DA; D-F) with P1a2b (10 À5 m) pre-incubation for 30 min then DCFH/DA was added (l ex = 405 nm (blue), l ex = 485 (green)). G) The summary data of cell apoptosis with P1a2b (2.5 10 À5 m) for 24, 48 and 72 h in different cell lines.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
54
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(54 citation statements)
references
References 28 publications
0
54
0
Order By: Relevance
“…Furthermore, Dong and his co‐workers further developed a facile multicomponent spiropolymerization route to construct heteroatom‐rich spiropolymers with clusteroluminescence (Figure 8C). [ 49 ] This one‐step MCP enjoys the superiorities of no catalyst, simple operation, high atom utilization, and handy monomers, which is perfectly in line with the concept for “green chemistry.” The resulting clusteroluminescent spiropolymers could serve as a potential fluorescent cancer marker and therapeutic agent due to its unique spirocyclic structures and clusterization‐triggered emission properties. Overall, the development of efficient one‐step MCP toward clusteroluminescent polymers is an attractive strategy for preparing new AIE polymers with nonconjugated structures and intriguing functions.…”
Section: One‐step Mcps For In Situ Generation Of Aie Polymersmentioning
confidence: 63%
See 1 more Smart Citation
“…Furthermore, Dong and his co‐workers further developed a facile multicomponent spiropolymerization route to construct heteroatom‐rich spiropolymers with clusteroluminescence (Figure 8C). [ 49 ] This one‐step MCP enjoys the superiorities of no catalyst, simple operation, high atom utilization, and handy monomers, which is perfectly in line with the concept for “green chemistry.” The resulting clusteroluminescent spiropolymers could serve as a potential fluorescent cancer marker and therapeutic agent due to its unique spirocyclic structures and clusterization‐triggered emission properties. Overall, the development of efficient one‐step MCP toward clusteroluminescent polymers is an attractive strategy for preparing new AIE polymers with nonconjugated structures and intriguing functions.…”
Section: One‐step Mcps For In Situ Generation Of Aie Polymersmentioning
confidence: 63%
“…[ 57 ] For example, Dong and co‐workers recently prepared a clusteroluminescent spiropolymer ( P5 , Figure A) based on the facile and catalyst‐free MCP shown in Figure 8C. [ 49 ] MDM2 is an oncogene with strong interaction with the tumor suppressor protein p53 and its primary function is to inhibit the activity of p53. The polymer structure of P5 largely resembles the known inhibitors of MDM2–p53 interaction.…”
Section: Functionalities Of Aie Polymersmentioning
confidence: 99%
“…Therefore, both of these PIFs have potential applications in biological imaging and therapy. [ 52,57,58 ]…”
Section: Resultsmentioning
confidence: 99%
“…Over the years, our group has been committed to the development of catalyst‐free MCCP based on diisocyanides, activated alkynes and various third monomers, and have prepared a series of functional heterocyclic polymers with good solubility and thermal stability, such as polyfurans, [ 48,49 ] poly(iminofuran‐arylene)s, [ 50 ] and spiropolymers. [ 51,52 ] In particular, the poly(iminofuran‐arylene)s have attracted much attention due to their cluster‐triggered emission properties, meanwhile the bromomethyl groups in the side chains provide the possibility for further post functionalization. However, the backbone of poly(iminofuran‐arylene)s contain aromatic groups in each structural unit, which makes the polymers have a certain biotoxicity from degradation metabolites and thus poor biocompatibility, which results in limited biological applications.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, Kim et al. synthesized a heteroatom‐containing spiropolymer P1a2b, which could intrinsically target MDM2 protein that is overexpressed in various cancerous cells [99] . P1a2b exhibited cluster‐triggered emission resulting from strong interaction with the MDM2 protein, which can be used to differentiate cancer cells from normal cells.…”
Section: Turn‐on Theranostics Based On In Situ Aggregationmentioning
confidence: 99%